Theratechnologies is a clinical-stage biopharmaceutical company focused on the development and commercialisation of innovative therapies. Its research pipeline focuses on specialised therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology.